Watchlist

Watchlist
Abbott Laboratories (ABT)
Abbott Laboratories (ABT)
DiaMedica Therapeutics Aims For $15 Million IPO
Quick Take DiaMedica Therapeutics ( DMAC ) intends to raise gross proceeds of $15 million from a U.S. IPO, according to an S-1 registration statement . The firm develops synthetic proteins for the treatment of neurological and kidney diseases. DMAC achieved positive initial safety trial…
Abbott Laboratories (ABT)